We collected information about R X I Pharmaceuticals C Hours for you. Follow the liks to find out everything about R X I Pharmaceuticals C Hours.
https://www.yellowpages.com/marlborough-ma/mip/rxi-pharmaceuticals-c-497242494
Get reviews, hours, directions, coupons and more for Rxi Pharmaceuticals C at 257 Simarano Dr Ste 101, Marlborough, MA 01752. Search for other Pharmaceutical Products in …
https://www.sec.gov/Archives/edgar/data/1533040/000157587217000024/sc13g.htm
(a) Name of Issuer RXi Pharmaceuticals Corporation (b) Address of Issuer’s Principal Executive Offices 257 Simarano Drive, Suite 101. Marloborough, MA 01752 . Item 2. (a) Name of Person Filing Alexey Wolfson (b) Address of Principal Business Office or, if none, Residence 10 Rocklawn Road. Westborough, MA 01581 (c) Citizenship U.S.A.
https://www.sec.gov/Archives/edgar/data/1533040/000120919117049646/xslFormDX01/primary_doc.xml
450,000 shares issued to LPC on 8/8/17 as initial consideration for put right granted to RXi under equity line; valued for purposes of this form at $0.58/share (closing stock …
http://investors.rxipharma.com/static-files/42e6edc8-c682-423b-97e0-0e0b66f5c427
Property of RXi Pharmaceuticals Clinical Development of RXI-109 for Dermal and Ocular Indications. NASDAQ: RXII. IBC’s 18. th. Annual Oligonucleotide and Peptide Therapeutics Conference – Long Beach, CA. May 12, 2016. Pamela A. Pavco, PhD RXi Pharmaceuticals
https://www.sec.gov/Archives/edgar/data/1533040/000119312517006979/d286088dex21.htm
Exhibit 2.1 . STOCK PURCHASE AGREEMENT . THIS STOCK PURCHASE AGREEMENT, dated as of January 6, 2017 (this “Agreement”), is by and among RXi Pharmaceuticals Corporation, a Delaware corporation (the “Buyer”), RXi Merger Sub, LLC, a Delaware limited liability company and wholly owned Subsidiary of Buyer (“Merger Sub”), MirImmune Inc., a Delaware corporation (the “Company”), the ...
https://www.sec.gov/Archives/edgar/data/1533040/000168316820000567/xslFormDX01/primary_doc.xml
Clarification of Response (if Necessary): In connection with the registered direct offering concurrent with the private placement, the Placement agent received $102,900 for fees and warrants to purchase up to 14,779 shares of common stock exercisable at an exercise price of $11.0375 per share.
Searching for R X I Pharmaceuticals C Hours?
You can just click the links above. The info is collected for you.
